Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Ferenci, P; Laferl, H; Scherzer, TM; Gschwantler, M; Maieron, A; Brunner, H; Stauber, R; Bischof, M; Bauer, B; Datz, C; Löschenberger, K; Formann, E; Staufer, K; Steindl-Munda, P; Austrian Hepatitis Study Group.
Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.
Gastroenterology. 2008; 135(2):451-458
Doi: 10.1053/j.gastro.2008.04.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Co-authors Med Uni Graz
-
Stauber Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Antiviral Agents - administration & dosage
-
Drug Administration Schedule -
-
Drug Therapy, Combination -
-
Female -
-
Genotype -
-
Hepacivirus - genetics
-
Hepatitis C - diagnosis
-
Hepatitis C Antibodies - blood
-
Humans -
-
Interferon-alpha - administration & dosage
-
Male -
-
Middle Aged -
-
Polyethylene Glycols - administration & dosage
-
Prospective Studies -
-
RNA, Viral - blood
-
Recombinant Proteins -
-
Ribavirin - administration & dosage
-
Treatment Outcome -
-
Viral Load -